Drug ID | DDPD00672 |
|
Drug Name | Chlorpropamide | |
Molecular Weight | 276.74 | |
Molecular Formula | C10H13ClN2O3S | |
CAS Number | 94-20-2 | |
SMILES | CCCNC(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1 | |
External Links | ||
DRUGBANK | DB00672 | |
PubChem Compound | 2727 | |
PDR | 3028 | |
Drugs.com | Drugs.com Drug Page |
Property Name | Property Value | Unit | Raw Value | Raw Unit | Reference |
---|---|---|---|---|---|
Log P | 2.27 | - | 2.27 | - | HANSCH,C ET AL. (1995) |
Melting Point | 129.5 | ℃ | 129.2-129.8 | ℃ | McLamore, W.M.; U S . Patent 3,349,124; October 24,1967; assigned to Chas. Pfizer Co., Inc. |
Water Solubility | 258.0 | mg/L | 258 | mg/L | YALKOWSKY,SH & DANNENFELSER,RM 1992) |
pKa | 5.13 | - | 5.13 | - | LIPINSKI,CA ET AL. (1991) |
Log S | -3.03 | - | -3.03 | - | ADME Research, USCD |
Property Name | Property Value | Unit | Raw Value | Raw Unit | Annotation | Reference |
---|---|---|---|---|---|---|
T Max | 3.0 | h | 2-4 | h | DRUGBANK | |
Metabolic | 80.0 | % | 80 | % | Liver metabolism; | DRUGBANK |
Clearance | 0.002700 | L/h/kg | 0.045 | ml/min/kg | intravenous injection, IV; human, homo sapiens; | Human Intravenous Pharmacokinetic Dataset |
Volume of Distribution | 0.19 | L/kg | 0.19 | L/kg | intravenous injection, IV; human, homo sapiens; | Human Intravenous Pharmacokinetic Dataset |
Half-life | 36.0 | h | ~36(25-60) | h | DRUGBANK | |
Half-life | 46.0 | h | 46 | h | intravenous injection, IV; human, homo sapiens; | Human Intravenous Pharmacokinetic Dataset |
Toxicity LD50 | 580.0 | mg/kg | 580.0 | mg/kg | Intraperitoneal, IP; Rattus, Rat; | DRUGBANK |
Eliminate Route | 85.0 | % | 80-90 | % | Urinary excretion; Oral single dose; | DRUGBANK |
Property Name | Property Value | Unit | Raw Value | Raw Unit | Annotation | Brand Name | Component | Reference |
---|---|---|---|---|---|---|---|---|
Max dose for adults | 750.0 | mg/day | 750 | mg/day | PO, oral | Chlorpropamide | chlorpropamide | PDR |